A promising new biologic prognostic model in diffuse large B-cell lymphoma

被引：1
|
作者：
Nathwani, Bharat N. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
BLOOD | 2012年 / 120卷 / 11期
关键词：
SURVIVAL; RITUXIMAB; SUBTYPES; PREDICTS;
D O I：
10.1182/blood-2012-07-441253
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2161 / 2162
页数：4
相关论文
共 50 条
  • [41] Pancreatic Diffuse Large B-cell Lymphoma in the
    Ullah, Asad
    Lee, Kue T.
    Malham, Kali
    Yasinzai, Abdul Qahar Khan
    Tareen, Bisma
    Lopes, Dara
    Wali, Agha
    Zarate, Luis Velasquez
    Waheed, Abdul
    Wiest, Maya
    Hakim, Resham
    Khan, Marjan
    Asif, Bina
    Patel, Nikhil
    Hakim, Sahar
    Kakar, Kaleemullah
    Heneidi, Saleh
    Karki, Nabin R.
    Sidhwa, Feroze
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [42] CD43 Expression Is an Adverse Prognostic Factor in Diffuse Large B-Cell Lymphoma
    Mitrovic, Zdravko
    Ilic, Ivana
    Nola, Marin
    Aurer, Igor
    Sonicki, Zdenko
    Basic-Kinda, Sandra
    Radman, Ivo
    Ajdukovic, Radmila
    Labar, Boris
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (02) : 133 - 137
  • [43] B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
    Young, Ryan M.
    Shaffer, Arthur L., III
    Phelan, James D.
    Staudt, Louis M.
    SEMINARS IN HEMATOLOGY, 2015, 52 (02) : 77 - 85
  • [44] Prognostic Role of Neutrophil to Lymphocyte Ratio at Diagnosis in Patients with Diffuse Large B-Cell Lymphoma
    Korkmaz, G.
    Ceran, F.
    Dagdas, S.
    Gunes, A. K.
    Sunu, C.
    Pepeler, M. S.
    Pamukcuoglu, M.
    Ozet, G.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (08) : 1012 - 1019
  • [45] Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma
    Wang, Yue
    Shi, Qing
    Shi, Zi-Yang
    Tian, Shuang
    Zhang, Mu-Chen
    Shen, Rong
    Fu, Di
    Dong, Lei
    Yi, Hong-Mei
    Ouyang, Bin-Shen
    Mu, Rong-Ji
    Cheng, Shu
    Wang, Li
    Xu, Peng-Peng
    Zhao, Wei -Li
    BLOOD ADVANCES, 2024, 8 (07) : 1587 - 1599
  • [46] Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era
    Liang, Xiping
    Hu, Renzhi
    Li, Qiying
    Wang, Chaoyu
    Liu, Yao
    EXPERIMENTAL HEMATOLOGY, 2023, 122 : 1 - 9
  • [47] Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
    Luan, Chunyan
    Wang, Fei
    Wei, Ning
    Chen, Baoan
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [48] Unraveling the Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic and Potential Therapeutic Implications
    Koumpis, Epameinondas
    Papoudou-Bai, Alexandra
    Papathanasiou, Konstantina
    Kolettas, Evangelos
    Kanavaros, Panagiotis
    Hatzimichael, Eleftheria
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 7048 - 7064
  • [49] Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
    Lu, Ting-Xun
    Wu, Shuang
    Cai, Dong-Yan
    Hong, Ting-Ting
    Zhang, Ying
    Gao, Hua-Qiang
    Hua, Hai-Ying
    Wu, Xiao-Hong
    BMC CANCER, 2019, 19 (1)
  • [50] Prognostic significance of double expressor lymphoma subtype in patient with diffuse large B-cell lymphoma
    Istiadi, Hermawan
    Sadhana, Udadi
    Puspasari, Dik
    Miranti, Ika Pawitra
    Karlowee, Vega
    Listiana, Devia Eka
    Prasetyo, Awal
    BALI MEDICAL JOURNAL, 2021, 10 (01) : 366 - 372
12345